Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Nature Cell Biology|July 5, 2022
CRISPR screening uncovers a central requirement for HHEX in pancreatic lineage commitment and plasticity restrictionDapeng Yang, Hyunwoo Cho, Zakieh Tayyebi, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibilityCharles Ng, Tak Shun Fung, Dayi Li, et al.Cancer Cell|September 5, 2020
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast CancerAmaia Arruabarrena-Aristorena, Jesper L V Maag, Srushti Kittane, et al.The Journal of Experimental Medicine|November 13, 2013
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoOmar Abdel-Wahab, Jie Gao, Mazhar Adli, et al.Nature Genetics|June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.Nature Genetics|January 15, 2020
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancerGuotai Xu, Sagar Chhangawala, Emiliano Cocco, et al.Nature Genetics|September 12, 2020
Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.Nature Genetics|May 16, 2017
PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.Nature Medicine|October 6, 2015
Loss of BAP1 function leads to EZH2-dependent transformationLindsay M LaFave, Wendy Béguelin, Richard Koche, et al.Blood|February 17, 2023
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosisAndrew J Dunbar, Dongjoo Kim, Min Lu, et al.Pageof 8